| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681733 | Clinical Neurology and Neurosurgery | 2018 | 5 Pages |
Abstract
LCM use in clinical practice was associated with greater rate of seizure freedom than in clinical trials. Discontinuation and occurrence of AEs were significantly more likely with faster titration and adding LCM to NCB agents.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Mark D. Baker, Bassel W. Abou-Khalil, Amir Arain, Pavan Tummala, Nabil J. Azar, Kevin F. Haas, Hasan H. Sonmezturk,